Intellectual Property Law and Copyright Laws

Dijital Telif Hakları Kanun Teklifi ("Teklif"), 10 Aralık 2025 tarihinde Türkiye Büyük Millet Meclisi ("TBMM") Başkanlığı'na sunulmuştur.

Under the Civil Code of the Republic of Armenia, a licensing agreement, the patent holder (licensor) undertakes to grant another party (licensee) the right to use an object protected by a patent within the scope stipulated by the agreement, while the licensee undertakes to pay the licensor the remuneration specified in the agreement and to perform other obligations provided therein.

On 10 December 2025, the Digital Copyright Bill ("Bill") was submitted to the Presidency of the Turkish Parliament.

Dijital Telif Hakları Kanun Teklifi ("Teklif"), 10 Aralık 2025 tarihinde Türkiye Büyük Millet Meclisi ("TBMM") Başkanlığı'na sunulmuştur.

We have all seen or read about examples of media created by generative artificial intelligence (GenAI): synthesized images, videos and audio that appear to represent real people or famous characters.

On 10 December 2025, the Digital Copyright Bill ("Bill") was submitted to the Presidency of the Turkish Parliament.

Under the Civil Code of the Republic of Armenia, a licensing agreement, the patent holder (licensor) undertakes to grant another party (licensee) the right to use an object protected by a patent within the scope stipulated by the agreement, while the licensee undertakes to pay the licensor the remuneration specified in the agreement and to perform other obligations provided therein.

We were delighted to join Adam Myers on cyber security podcast Tales from the CyberLab, where Partners David Robinson and Fiona Phillips explored the rising – and often hidden – threat of intellectual property theft.

This article explores how a well‑structured intellectual property strategy underpins every ambitious fashion business, protecting everything from brand identity to innovative materials and manufacturing techniques.

They are both viewed as having the potential to provide world-changing applications which will improve many lives. However, both technologies face an issue with public opinion, which will likely provide an obstacle...

The UK IPO recently announced that it would be increasing its fees from the 1st April 2026, to help address inflation and ease future cost pressures.

A biosimilar is defined by the European Medicines Agency (EMA) as: "a biological medicine highly similar to another biological medicine already approved in the EU...